Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapa...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
s.l.: Nature Publishing Group ; 2002 |
|---|
| Umfang: |
8 |
|---|
| Reproduktion: |
Nature Archives 1869 - 2009 |
|---|---|
| Übergeordnetes Werk: |
In: Nature medicine - New York, NY : Nature America Inc., 1995, 8(2002), 2, Seite 128-135 |
| Übergeordnetes Werk: |
volume:8 ; year:2002 ; number:2 ; month:00 ; pages:128-135 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1038/nm0202-128 |
|---|
| Katalog-ID: |
NLEJ231656750 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ231656750 | ||
| 003 | DE-627 | ||
| 005 | 20230506114939.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 110224s2002 xxu|||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/nm0202-128 |2 doi | |
| 035 | |a (DE-627)NLEJ231656750 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 245 | 1 | 0 | |a Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| 264 | 1 | |a [s.l.] |b Nature Publishing Group |c 2002 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... | ||
| 533 | |f Nature Archives 1869 - 2009 | ||
| 700 | 1 | |a von Breitenbuch, Philipp |4 oth | |
| 700 | 1 | |a Steinbauer, Markus |4 oth | |
| 700 | 1 | |a Koehl, Gudrun |4 oth | |
| 700 | 1 | |a Flegel, Stefanie |4 oth | |
| 700 | 1 | |a Hornung, Matthias |4 oth | |
| 700 | 1 | |a Bruns, Christiane J. |4 oth | |
| 700 | 1 | |a Zuelke, Carl |4 oth | |
| 700 | 1 | |a Farkas, Stefan |4 oth | |
| 700 | 1 | |a Anthuber, Matthias |4 oth | |
| 700 | 1 | |a Jauch, Karl-Walter |4 oth | |
| 700 | 1 | |a Guba, Markus |4 oth | |
| 700 | 1 | |a Geissler, Edward K. |4 oth | |
| 773 | 0 | 8 | |i In |t Nature medicine |d New York, NY : Nature America Inc., 1995 |g 8(2002), 2, Seite 128-135 |w (DE-627)NLEJ22768236X |w (DE-600)1484517-9 |x 1546-170X |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2002 |g number:2 |g month:00 |g pages:128-135 |g extent:8 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/nm0202-128 |q application/pdf |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-NTA | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2002 |e 2 |c 0 |h 128-135 |g 8 | ||
| matchkey_str |
article:1546170X:2002----::aayiihbtpiaynmtsaitmrrwhyninignssnovmnov |
|---|---|
| hierarchy_sort_str |
2002 |
| publishDate |
2002 |
| allfields |
10.1038/nm0202-128 doi (DE-627)NLEJ231656750 DE-627 ger DE-627 rakwb eng XD-US Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [s.l.] Nature Publishing Group 2002 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... Nature Archives 1869 - 2009 von Breitenbuch, Philipp oth Steinbauer, Markus oth Koehl, Gudrun oth Flegel, Stefanie oth Hornung, Matthias oth Bruns, Christiane J. oth Zuelke, Carl oth Farkas, Stefan oth Anthuber, Matthias oth Jauch, Karl-Walter oth Guba, Markus oth Geissler, Edward K. oth In Nature medicine New York, NY : Nature America Inc., 1995 8(2002), 2, Seite 128-135 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 http://dx.doi.org/10.1038/nm0202-128 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 8 2002 2 0 128-135 8 |
| spelling |
10.1038/nm0202-128 doi (DE-627)NLEJ231656750 DE-627 ger DE-627 rakwb eng XD-US Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [s.l.] Nature Publishing Group 2002 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... Nature Archives 1869 - 2009 von Breitenbuch, Philipp oth Steinbauer, Markus oth Koehl, Gudrun oth Flegel, Stefanie oth Hornung, Matthias oth Bruns, Christiane J. oth Zuelke, Carl oth Farkas, Stefan oth Anthuber, Matthias oth Jauch, Karl-Walter oth Guba, Markus oth Geissler, Edward K. oth In Nature medicine New York, NY : Nature America Inc., 1995 8(2002), 2, Seite 128-135 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 http://dx.doi.org/10.1038/nm0202-128 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 8 2002 2 0 128-135 8 |
| allfields_unstemmed |
10.1038/nm0202-128 doi (DE-627)NLEJ231656750 DE-627 ger DE-627 rakwb eng XD-US Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [s.l.] Nature Publishing Group 2002 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... Nature Archives 1869 - 2009 von Breitenbuch, Philipp oth Steinbauer, Markus oth Koehl, Gudrun oth Flegel, Stefanie oth Hornung, Matthias oth Bruns, Christiane J. oth Zuelke, Carl oth Farkas, Stefan oth Anthuber, Matthias oth Jauch, Karl-Walter oth Guba, Markus oth Geissler, Edward K. oth In Nature medicine New York, NY : Nature America Inc., 1995 8(2002), 2, Seite 128-135 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 http://dx.doi.org/10.1038/nm0202-128 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 8 2002 2 0 128-135 8 |
| allfieldsGer |
10.1038/nm0202-128 doi (DE-627)NLEJ231656750 DE-627 ger DE-627 rakwb eng XD-US Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [s.l.] Nature Publishing Group 2002 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... Nature Archives 1869 - 2009 von Breitenbuch, Philipp oth Steinbauer, Markus oth Koehl, Gudrun oth Flegel, Stefanie oth Hornung, Matthias oth Bruns, Christiane J. oth Zuelke, Carl oth Farkas, Stefan oth Anthuber, Matthias oth Jauch, Karl-Walter oth Guba, Markus oth Geissler, Edward K. oth In Nature medicine New York, NY : Nature America Inc., 1995 8(2002), 2, Seite 128-135 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 http://dx.doi.org/10.1038/nm0202-128 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 8 2002 2 0 128-135 8 |
| allfieldsSound |
10.1038/nm0202-128 doi (DE-627)NLEJ231656750 DE-627 ger DE-627 rakwb eng XD-US Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor [s.l.] Nature Publishing Group 2002 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier [Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... Nature Archives 1869 - 2009 von Breitenbuch, Philipp oth Steinbauer, Markus oth Koehl, Gudrun oth Flegel, Stefanie oth Hornung, Matthias oth Bruns, Christiane J. oth Zuelke, Carl oth Farkas, Stefan oth Anthuber, Matthias oth Jauch, Karl-Walter oth Guba, Markus oth Geissler, Edward K. oth In Nature medicine New York, NY : Nature America Inc., 1995 8(2002), 2, Seite 128-135 (DE-627)NLEJ22768236X (DE-600)1484517-9 1546-170X nnns volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 http://dx.doi.org/10.1038/nm0202-128 application/pdf Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE AR 8 2002 2 0 128-135 8 |
| language |
English |
| source |
In Nature medicine 8(2002), 2, Seite 128-135 volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 |
| sourceStr |
In Nature medicine 8(2002), 2, Seite 128-135 volume:8 year:2002 number:2 month:00 pages:128-135 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Nature medicine |
| authorswithroles_txt_mv |
von Breitenbuch, Philipp @@oth@@ Steinbauer, Markus @@oth@@ Koehl, Gudrun @@oth@@ Flegel, Stefanie @@oth@@ Hornung, Matthias @@oth@@ Bruns, Christiane J. @@oth@@ Zuelke, Carl @@oth@@ Farkas, Stefan @@oth@@ Anthuber, Matthias @@oth@@ Jauch, Karl-Walter @@oth@@ Guba, Markus @@oth@@ Geissler, Edward K. @@oth@@ |
| publishDateDaySort_date |
2002-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ22768236X |
| id |
NLEJ231656750 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ231656750</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506114939.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">110224s2002 xxu|||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/nm0202-128</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ231656750</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XD-US</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[s.l.]</subfield><subfield code="b">Nature Publishing Group</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ...</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Nature Archives 1869 - 2009</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Breitenbuch, Philipp</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinbauer, Markus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koehl, Gudrun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flegel, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hornung, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruns, Christiane J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zuelke, Carl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farkas, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anthuber, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jauch, Karl-Walter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guba, Markus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geissler, Edward K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nature medicine</subfield><subfield code="d">New York, NY : Nature America Inc., 1995</subfield><subfield code="g">8(2002), 2, Seite 128-135</subfield><subfield code="w">(DE-627)NLEJ22768236X</subfield><subfield code="w">(DE-600)1484517-9</subfield><subfield code="x">1546-170X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:2</subfield><subfield code="g">month:00</subfield><subfield code="g">pages:128-135</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1038/nm0202-128</subfield><subfield code="q">application/pdf</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-NTA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2002</subfield><subfield code="e">2</subfield><subfield code="c">0</subfield><subfield code="h">128-135</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| series2 |
Nature Archives 1869 - 2009 |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ22768236X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| publishPlace |
[s.l.] |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1546-170X |
| topic_title |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| publisher |
Nature Publishing Group |
| publisherStr |
Nature Publishing Group |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b p v bp bpv m s ms g k gk s f sf m h mh c j b cj cjb c z cz s f sf m a ma k w j kwj m g mg e k g ek ekg |
| hierarchy_parent_title |
Nature medicine |
| hierarchy_parent_id |
NLEJ22768236X |
| hierarchy_top_title |
Nature medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ22768236X (DE-600)1484517-9 |
| title |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| spellingShingle |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| ctrlnum |
(DE-627)NLEJ231656750 |
| title_full |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| journal |
Nature medicine |
| journalStr |
Nature medicine |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2002 |
| contenttype_str_mv |
zzz |
| container_start_page |
128 |
| container_volume |
8 |
| physical |
8 |
| format_se |
Elektronische Aufsätze |
| countryofpublication_str_mv |
XD-US |
| doi_str_mv |
10.1038/nm0202-128 |
| title_sort |
rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| title_auth |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| abstract |
[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... |
| abstractGer |
[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... |
| abstract_unstemmed |
[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ... |
| collection_details |
GBV_USEFLAG_U ZDB-1-NTA GBV_NL_ARTICLE |
| container_issue |
2 |
| title_short |
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor |
| url |
http://dx.doi.org/10.1038/nm0202-128 |
| remote_bool |
true |
| author2 |
von Breitenbuch, Philipp Steinbauer, Markus Koehl, Gudrun Flegel, Stefanie Hornung, Matthias Bruns, Christiane J. Zuelke, Carl Farkas, Stefan Anthuber, Matthias Jauch, Karl-Walter Guba, Markus Geissler, Edward K. |
| author2Str |
von Breitenbuch, Philipp Steinbauer, Markus Koehl, Gudrun Flegel, Stefanie Hornung, Matthias Bruns, Christiane J. Zuelke, Carl Farkas, Stefan Anthuber, Matthias Jauch, Karl-Walter Guba, Markus Geissler, Edward K. |
| ppnlink |
NLEJ22768236X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1038/nm0202-128 |
| up_date |
2024-07-05T23:27:16.938Z |
| _version_ |
1803783542610591745 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ231656750</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506114939.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">110224s2002 xxu|||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1038/nm0202-128</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ231656750</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="c">XD-US</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[s.l.]</subfield><subfield code="b">Nature Publishing Group</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">[Auszug] Conventional immunosuppressive drugs have been used effectively to prevent immunologic rejection in organ transplantation. Individuals taking these drugs are at risk, however, for the development and recurrence of cancer. In the present study we show that the new immunosuppressive drug rapamycin ...</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Nature Archives 1869 - 2009</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">von Breitenbuch, Philipp</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steinbauer, Markus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Koehl, Gudrun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Flegel, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hornung, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bruns, Christiane J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zuelke, Carl</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Farkas, Stefan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anthuber, Matthias</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jauch, Karl-Walter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Guba, Markus</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geissler, Edward K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Nature medicine</subfield><subfield code="d">New York, NY : Nature America Inc., 1995</subfield><subfield code="g">8(2002), 2, Seite 128-135</subfield><subfield code="w">(DE-627)NLEJ22768236X</subfield><subfield code="w">(DE-600)1484517-9</subfield><subfield code="x">1546-170X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:8</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:2</subfield><subfield code="g">month:00</subfield><subfield code="g">pages:128-135</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1038/nm0202-128</subfield><subfield code="q">application/pdf</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-NTA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">8</subfield><subfield code="j">2002</subfield><subfield code="e">2</subfield><subfield code="c">0</subfield><subfield code="h">128-135</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.3972616 |